Clinical Trial Update: Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Left Ventricular Systolic Dysfunction
• Low Cardiac Output Syndrome

Drugs mentioned

• Simdax (levosimendan)

Snippet

Sponsor: Tenax Therapeutics, Inc. | Conditions: Coronary Artery Bypass Grafting, Mitral Valve Surgery | Phase 3 | Status: COMPLETED | Results posted: 2018-05-22